藥明生物
WuXi Biologics (Cayman) IncUSUSDWuXi Biologics (Cayman) Inc (US:WXIBF) — Biotechnology. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О Компании
- Сайт
- wuxibiologics.com
- Сектор
- Healthcare · Biotechnology
- Штаб-Квартира
- Wuxi, China
- Генеральный Директор
- Zhisheng Chen
- Сотрудники
- 14 705
- Акций в Обращении
- Свободное Обращение
- 3.71 млрд
- Рыночная Капитализация
- 216.75 млрд HKD
- Инсайдеры
- 10.12%
- Институциональные Инвесторы
- 36.36%
- Правовая Форма
- OSBR
- ISIN
- KYG970081173
- LEI
- 5493001TD2TH6VDTJU11
Описание
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Новости Этой Недели
Пресс-релизы с сайта для инвесторов компании, обновляемые ежедневно. Ссылки ведут на сайт компании. Заголовки написаны на оригинальном языке, как и на сайте компании.
Крупнейшие Держатели
| Держатель | Доля | Акции | Дата Отчета |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.34% | 55.13 млн | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 1.27% | 52.41 млн | 2026-07-31 |
| Chen (Zhisheng) (Chief E… | ≈1.19% | 49.19 млн | 2026-09-11 |
| iShares, Inc.-iShares Co… | 0.97% | 40.12 млн | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 0.92% | 37.93 млн | 2026-05-31 |
| American Century ETF Tru… | 0.27% | 11.01 млн | 2026-08-31 |
| J.P. Morgan Exch-Trd Fd.… | 0.26% | 10.87 млн | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.22% | 8.96 млн | 2026-07-31 |
| iShares, Inc.-iShares MS… | 0.22% | 8.91 млн | 2026-08-31 |
| Baird Funds Inc-Baird Ch… | 0.21% | 8.77 млн | 2026-07-31 |
| iShares Trust-iShares MS… | 0.21% | 8.76 млн | 2026-08-31 |
| Zhou (Weichang) (Chief T… | ≈0.14% | 5.6 млн | 2025-06-02 |
| Gu (Xuejun Sherry) (Chie… | ≈0.03% | 1.37 млн | 2026-08-24 |
| Boston Common Asset Mana… | 0.02% | 869 000 | 2024-03-31 |
| Li (Ge) (Chairman of the… | — | — | 2026-01-20 |
